Despite these limitations, the researchers believe the study confirmed the efficacy and safety of bimekizumab and brodalumab ...
Treatment with tuspetinib in combination with Venclexta and Vidaza in newly diagnosed acute myeloid leukemia showed safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback